AR079479A1 - Composiciones oftalmicas no irritantes de povidona iodada - Google Patents

Composiciones oftalmicas no irritantes de povidona iodada

Info

Publication number
AR079479A1
AR079479A1 ARP100104657A ARP100104657A AR079479A1 AR 079479 A1 AR079479 A1 AR 079479A1 AR P100104657 A ARP100104657 A AR P100104657A AR P100104657 A ARP100104657 A AR P100104657A AR 079479 A1 AR079479 A1 AR 079479A1
Authority
AR
Argentina
Prior art keywords
iodada
povidona
ophthalmic compositions
irritating
irritating ophthalmic
Prior art date
Application number
ARP100104657A
Other languages
English (en)
Original Assignee
Foresight Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44305700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR079479(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Foresight Biotherapeutics Inc filed Critical Foresight Biotherapeutics Inc
Publication of AR079479A1 publication Critical patent/AR079479A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicacion 1: 1. Una preparacion oftálmica caracterizada porque comprende: a. povidona iodada (PVP-l) en una concentracion de aproximadamente 0,1% a aproximadamente 2,5% de dicha preparacion oftálmica, b. al menos un miembro seleccionado del grupo que consiste en un lubricante y un agente de enfriamiento en una concentracion que no resulta irritante al ojo; y c. opcionalmente, uno o varios de los miembros seleccionados del grupo que consiste en alcanfor, bomeol, un lubricante, un emoliente, un antiinflamatorio esteroide y un antiinflamatorio no esteroide. Método de tratamiento.
ARP100104657A 2009-12-15 2010-12-15 Composiciones oftalmicas no irritantes de povidona iodada AR079479A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28669709P 2009-12-15 2009-12-15

Publications (1)

Publication Number Publication Date
AR079479A1 true AR079479A1 (es) 2012-01-25

Family

ID=44305700

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100104657A AR079479A1 (es) 2009-12-15 2010-12-15 Composiciones oftalmicas no irritantes de povidona iodada

Country Status (16)

Country Link
US (1) US20130177522A1 (es)
EP (1) EP2512230A4 (es)
JP (3) JP2013514373A (es)
KR (2) KR20120112537A (es)
CN (2) CN104906580A (es)
AR (1) AR079479A1 (es)
AU (1) AU2010339993A1 (es)
BR (1) BR112012014260A2 (es)
CA (1) CA2784492C (es)
CL (1) CL2012001583A1 (es)
EC (1) ECSP12012037A (es)
HK (1) HK1211216A1 (es)
MX (1) MX364441B (es)
PE (2) PE20121498A1 (es)
TW (3) TWI618539B (es)
WO (1) WO2011084473A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
AU2010339993A1 (en) * 2009-12-15 2012-07-26 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
PE20141070A1 (es) * 2011-05-12 2014-09-14 Foresigth Biotherapeutics Inc Composiciones estables de povidona yodada con antiinflamatorios esteroideos o no esteroideos
GB201114725D0 (en) * 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
TW202023575A (zh) * 2011-09-16 2020-07-01 美商遠景生物製藥股份有限公司 安定之普維酮—碘組成物
CN102429862B (zh) 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
TW201400117A (zh) * 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
JP6161500B2 (ja) * 2012-10-05 2017-07-12 ロート製薬株式会社 ブロムフェナク含有組成物
JP6304474B2 (ja) * 2013-01-31 2018-04-04 ロート製薬株式会社 点眼剤
JP6304475B2 (ja) * 2013-01-31 2018-04-04 ロート製薬株式会社 点眼剤
RS59271B1 (sr) * 2013-02-01 2019-10-31 Allergan Inc Veštačke suze koje se sastoje od natrijum-hijaluronata i karboksimetil celuloze
WO2014160579A1 (en) * 2013-03-25 2014-10-02 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
US9630909B2 (en) 2013-06-27 2017-04-25 Mylan Laboratories Ltd Process for the preparation of nepafenac
US20150064129A1 (en) * 2013-09-04 2015-03-05 Taiwan Biotech Co., Ltd. Wound healing composition
CN103877120B (zh) * 2014-04-02 2017-07-21 程予良 一种膏药
AU2016344349B2 (en) * 2015-10-25 2022-05-19 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
JP6255134B1 (ja) * 2016-11-02 2017-12-27 ヴェローチェ・バイオファーマ・エルエルシー 耳炎の治療のための組成物および方法
BR112019021917A8 (pt) 2017-04-21 2023-03-21 Novaliq Gmbh Composições de iodo
CN108853074A (zh) * 2017-05-10 2018-11-23 武汉先路医药科技股份有限公司 一种含有溴芬酸钠水合物的药物水性滴眼液及其制备方法
WO2020061249A2 (en) * 2018-09-21 2020-03-26 Ps Therapies Ltd. Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
US20240082188A1 (en) * 2021-01-21 2024-03-14 Taejoon Pharmaceutical Co., Ltd. Ophthalmic composition
US20230181625A1 (en) * 2021-12-14 2023-06-15 Harrow Ip, Llc Method and composition for treating infectious conjunctivitis
CN117338787A (zh) * 2023-11-24 2024-01-05 南京恒道医药科技股份有限公司 一种眼用药物组合物及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200103B (en) * 1987-04-01 1990-04-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for treating lack of epithelium
CA1303503C (en) * 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
US5126127A (en) * 1991-07-16 1992-06-30 Euroceltique, S.A. Stabilized PVP-I solutions
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro Celtique Sa Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
US5849291A (en) * 1994-10-17 1998-12-15 Symbollon Corporation Opthalmic non-irritating iodine medicament
CN1204961A (zh) * 1996-09-26 1999-01-13 老笃制药株式会社 滴眼剂
AU775500B2 (en) * 1999-05-27 2004-08-05 Euro-Celtique S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents
JP4748289B2 (ja) * 2000-06-23 2011-08-17 ライオン株式会社 点眼剤、眼科用組成物及び吸着抑制方法
ES2281569T3 (es) * 2001-12-21 2007-10-01 Senju Pharmaceutical Co., Ltd. Gotas para los ojos.
ES2212907B1 (es) * 2003-01-20 2005-12-16 Luis Ignacio Olcina Portilla Preparados oftalmologicos a base de povidona yodada.
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
PT1791791T (pt) * 2004-09-27 2019-09-12 Special Water Patents B V Métodos e composições para tratamento de água
US20080132444A1 (en) * 2004-10-09 2008-06-05 Xiaoling Li Ocular Agent Delivery Systems
CN100335035C (zh) * 2004-10-25 2007-09-05 张帆 一种滴眼剂
JP2006219475A (ja) * 2004-12-28 2006-08-24 Rohto Pharmaceut Co Ltd 眼局所適用製剤
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
JP2007277135A (ja) * 2006-04-05 2007-10-25 Mie Univ 創傷治療用外用剤
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
WO2009097123A1 (en) * 2008-01-28 2009-08-06 Foresight Biotherapeutics, Inc. Device for in-situ generation of povidone-iodine compositions
US20090263345A1 (en) * 2008-01-28 2009-10-22 Foresight Biotherapeutics, Inc. Otic compositions for the treatment of infections of the internal and external ear in mammals
JP2008189677A (ja) * 2008-03-10 2008-08-21 Rohto Pharmaceut Co Ltd 洗浄剤
PL2291081T3 (pl) * 2008-06-12 2021-01-25 Takeda Pharmaceutical Company Limited Jodopowidon, nowy alternatywny środek konserwujący do kompozycji okulistycznych
US8753561B2 (en) * 2008-06-20 2014-06-17 Baxter International Inc. Methods for processing substrates comprising metallic nanoparticles
AU2010339993A1 (en) * 2009-12-15 2012-07-26 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液

Also Published As

Publication number Publication date
JP2018030871A (ja) 2018-03-01
HK1211216A1 (en) 2016-05-20
MX364441B (es) 2019-04-26
CA2784492C (en) 2020-06-30
MX2012006881A (es) 2012-07-04
NZ751915A (en) 2020-09-25
KR20190049931A (ko) 2019-05-09
PE20160526A1 (es) 2016-05-29
PE20121498A1 (es) 2012-11-30
TWI561239B (en) 2016-12-11
CN102811610A (zh) 2012-12-05
BR112012014260A2 (pt) 2015-09-15
AU2010339993A1 (en) 2012-07-26
TWI618539B (zh) 2018-03-21
CA2784492A1 (en) 2011-07-14
KR20120112537A (ko) 2012-10-11
CN104906580A (zh) 2015-09-16
WO2011084473A1 (en) 2011-07-14
CL2012001583A1 (es) 2013-01-11
TW201630614A (zh) 2016-09-01
TW201143783A (en) 2011-12-16
ECSP12012037A (es) 2012-08-31
EP2512230A4 (en) 2013-05-22
JP2016028101A (ja) 2016-02-25
EP2512230A1 (en) 2012-10-24
JP2013514373A (ja) 2013-04-25
CN102811610B (zh) 2016-05-18
TWI620569B (zh) 2018-04-11
TW201717973A (zh) 2017-06-01
US20130177522A1 (en) 2013-07-11

Similar Documents

Publication Publication Date Title
AR079479A1 (es) Composiciones oftalmicas no irritantes de povidona iodada
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
ES2524320T3 (es) Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo
BR112012033077A2 (pt) composição farmacêutica para administração intravenosa, método para tratar ou previnir uma infecção, e, kit
MA41197B1 (fr) Traitement de le pemphigus
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
AR057422A1 (es) Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma
MX2022009942A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
BR112015023520A2 (pt) purificação do conjugado de anticorpo-fármaco (adc)
MA40768A (fr) Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue
BR112014021498A2 (pt) composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado
BR112014017650A2 (pt) composições e uso de ésteres de forbol
PE20142314A1 (es) Composiciones intranasales de dexmedetomidina y metodos de uso de ellas
EP4249431A3 (en) Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions
BR112012033391A8 (pt) kit contraceptivo, método contraceptivo para uma paciente do sexo feminino necessitando do mesmo e composição farmacêutica compreendendo drospirenova.
MA38576A1 (fr) Formulations de colchicine à libération prolongée et procédés d'utilisation de ces dernières
AR070025A1 (es) Uso de derivados de 1-amino-alquilciclohexano para el tratamiento del tinnitus coclear y composicion farmaceutica
AR098899A1 (es) Composiciones para el cuidado oral y métodos
BR112014020271A8 (pt) Composição farmacêutica e métodos para diminuir a frequência de micção em paciente
NI201100119A (es) Composición de liberación pulsatil de sildenafil y proceso para prepararla.
AR094009A1 (es) Composiciones fluidas para la higiene bucal contentivas de peroxido
BR112012027393A2 (pt) composto da fórmula geral i, composição farmacêutica, uso de um composto e método de tratamento de qualquer mamífero, notadamente um humano, afetado por câncer
ATE548043T1 (de) Polymorphe von 3-o-(3',3'- dimethylsuccinyl)betulinsäure-di-n-methyl-d- glucamin
BR112015013820A2 (pt) composições de cuidado oral para branqueamento dental

Legal Events

Date Code Title Description
FC Refusal